Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
ESSA Pharma Inc. (EPIX) had Return on Investments of -3.68% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.00M |
|
-- |
|
-- |
|
$4.90M |
|
$-4.90M |
|
$0.89M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.90M |
|
$-4.88M |
|
44.39M |
|
44.39M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$110.50M |
|
-- |
|
-- |
|
$110.50M |
|
$1.60M |
|
-- |
|
-- |
|
$1.60M |
|
$108.90M |
|
$108.90M |
|
$108.90M |
|
44.39M |
|
| Cash Flow Statement Financials | |
$-17.52M |
|
$-0.24M |
|
-- |
|
$103.71M |
|
$85.95M |
|
$-17.76M |
|
$3.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
69.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.68% |
|
-3.68% |
|
-3.62% |
|
|
Return on Investments |
-3.68% |
$2.45 |
|
$-0.39 |
|
$-0.39 |
|